ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
PARADIGM REPORTS OSTEOARTHRITIS PAIN REDUCED BY 50%
Published: 01/03/18, 08:18am (AEST)•3 pages